We are excited to announce that Dr. Polymnia Louka, our new postdoctoral researcher, has successfully secured €150,000 in funding through the European Marie-Curie Co-Fund. The grant will support her research project titled “Identifying the Effects of Ketamine and Its Metabolites on Depression-Induced Impairment in Bone Health.”

Dr. Louka’s project aims to address a critical gap in understanding the connection between depression and bone health, particularly how rapid-acting antidepressants like ketamine can impact bone physiology. Her research will explore the effects of ketamine and its metabolites on bone remodeling, both in vitro and in vivo, and investigate potential synergistic benefits of combining ketamine with other agents such as sulforaphane.

This interdisciplinary study will be conducted in collaboration with the University of Cyprus and the Royal Veterinary College. Under the mentorship of Dr. Zanos and Prof. Santama, the project aims to advance our understanding of mental and physical health, potentially leading to new therapeutic approaches.

Congratulations to Dr. Louka on this remarkable achievement, and we look forward to the impactful results from this innovative research!!